Skip to main content
News > News > Tauriga Sciences Inc. Highlights Pilus Energy’s Genetic Rights Management (“GeRM”) Keys for the Protection of Its Synthetic Biology Based BactoBots(TM)

Tauriga Sciences Inc. Highlights Pilus Energy’s Genetic Rights Management (“GeRM”) Keys for the Protection of Its Synthetic Biology Based BactoBots(TM)

NEW YORK, Jan. 24, 2014 (GLOBE NEWSWIRE) — Tauriga Sciences, Inc. (OTCQB:TAUG) or (“Tauriga” or “the Company”), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today highlighted the Genetic Rights Management (“GeRM”) synthetic biology security system developed for Pilus Energy LLC (“Pilus Energy”) to protect its proprietary BactoBots™ technology platform.

The anti-theft and protection against environmental release GeRM system is engineered into Pilus Energy’s genetically enhanced products, specifically its synthetic biology based bacterial robot (“BactoBots™”). GeRM “keys” are hidden in a consumable powder. That powder is occasionally added to the wastewater in the BactoBots operating environment. If the dissolved GeRM keys are separated from the BactoBots, then the BactoBots self-destruct; beginning with the corruption of their deoxyribonucleic acid (“DNA”) and/or ribonucleic acid (“RNA”).

As a result, Pilus Energy is able to rapidly license its technology platform and expertise in synthetic biology engineering to any reputable firm in the world. A Licensee is enabled to manufacture (“Manufacturer”) the BactoBots™ and provide the commercial product to an in-market licensed Distributor (“Distributor”). Pilus Energy then sends the consumable GeRM key powder to the Distributor, who packages it with the BactoBots™ for the Distributor’s marketplace.

In this way, Pilus Energy facilitates a global synthetic biology market with an integrated system of anti-theft and another level of protection against environmental release. Because GeRM enables licensing and consumable sales, Pilus Energy does not require the facilities, personnel, and regulatory overhead that come with centralized production and distribution of products.

In short, GeRM keys enable local control and economic development with lower overhead and risk. By licensing the knowledge of manufacturing BactoBots™, Pilus Energy creates a force-multiplier effect.

The GeRM Keys’ system of protection is protected by the following Intellectual Property (“IP”): USA Provisional Patent Filing, 61/790-735, March 15, 2013.

Titled: COMPOSITIONS, SYSTEMS AND METHODS FOR PROTECTING GENETICALLY MODIFIED ORGANISMS FROM UNAUTHORIZED USE OR RELEASE INTO THE ENVIRONMENT

Tauriga’s CEO Seth M. Shaw, expressed, “The Company continues to present to a number of institutional investors and questions have arisen as to Pilus Energy’s ability to protect its proprietary technology from theft, cloning, and reverse engineering. The scientists at Pilus Energy have established an outstanding system of protection through the GeRM Keys and as a result, the technology can be efficiently exported to the global marketplace without risk of counterfeiting or theft. Tauriga’s management has worked extremely hard to complete the acquisition of Pilus Energy and anticipates that the closing of such acquisition will be announced within days.”

Bacterial Robotics, CEO, Jason E. Barkeloo, finished, “Our GeRM synthetic biology security system enables a business model that disincentives reverse-engineering and theft. Apple Computer’s iTunes® model made theft of digital assets using Napster irrelevant. With iTunes® it was cheaper and less risky to pay ninety-nine cents for a song, load it to your iPod®, and go, than it was to hack the digital rights management, or DRM, and steal the song. Similarly, GeRM makes it easier to distribute the knowledge to manufacture and distribute BactoBots. Sure, someone can hack the GeRM. But with the economic incentive and intellectual property protections, why not just license it?”

An illustrative briefing of the GeRM-enabled security system will be available later today on the corporate website for Tauriga Sciences, Inc. at: (www.taurigasciences.com).

On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC (“Pilus Energy”), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga’s board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company’s new corporate website can be found at (www.tauriga.com).

About Pilus Energy LLC

A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy’s web site, (www.pilusenergy.com).

About Bacterial Robotics LLC

A pioneer in the emerging synthetic biology industry, Bacterial Robotics is headquartered in Cincinnati, Ohio (USA). The Company specializes in identifying markets for developing and deploying BactoBots(TM) and ViruBots(TM); microscopic organism-based robots that produce, build, sense, and perform functions. Please visit the corporate website at http://bacterialrobotics.com for more information.

DISCLAIMER:

Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.